Full-Time

Staff/Principal Software Engineer

Instrument Software

Posted on 4/16/2024

Volta Labs

Volta Labs

51-200 employees

Develops software for genomic data analysis

Enterprise Software
Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Requires onsite presence in Seaport District, Boston, MA.

Category
Backend Engineering
Full-Stack Engineering
Software QA & Testing
Software Engineering
Required Skills
Python

You match the following Volta Labs's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Deep understanding of modern Python capabilities
  • Experience in designing, launching, and executing software development roadmaps
  • Experience in growing an engineering team
  • Technical leadership experience
  • Ability to work onsite at the Seaport Office in Boston, MA
Responsibilities
  • Partnering with the Application Development team to outline requirements for new processes
  • Designing, developing, and implementing code for new processes
  • Identifying new data points for performance measurement
  • Mentoring junior team members
  • Crafting a roadmap for software capabilities
  • Participating in hiring decisions and onboarding junior engineers
  • Shipping new chemical process capabilities to software

Volta Labs focuses on genomic analysis by developing software tools that help research institutions, clinical laboratories, and biotech companies process genomic data accurately and efficiently. Their software is designed to generate precise results through advanced scripting, making it easier for clients to analyze DNA and genes. Unlike many competitors, Volta Labs combines software development with biochemistry expertise, allowing them to create tailored solutions for the growing genomics market. The company's goal is to enhance the capabilities of genomic analysis, supporting advancements in personalized medicine and biotechnology while generating revenue through software licensing and service contracts.

Company Size

51-200

Company Stage

Seed

Total Funding

$23.6M

Headquarters

Cambridge, Massachusetts

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for automated genomic solutions due to personnel shortages.
  • Partnerships with Element Biosciences and IDT enhance accessibility and efficiency.
  • Volta Labs' technology streamlines genomic data processing, meeting high market demand.

What critics are saying

  • Emerging startups in genomics automation threaten Volta Labs' market share.
  • Rapid technological advancements may render current technologies obsolete.
  • Data privacy concerns could arise from Volta Labs' data monetization strategies.

What makes Volta Labs unique

  • Volta Labs integrates digital fluidics technology for efficient genomic analysis.
  • The Callisto Sample Prep System reduces hands-on time and operator training.
  • Volta Labs offers platform-agnostic solutions for next-generation sequencing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Paid Parental Leave

Paid Time Off

Sponsored Commuter Benefit Plans

Robust Equity Program

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-1%

2 year growth

-3%
PR Newswire
Oct 30th, 2024
Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

Partners like Volta Labs collaborate closely with PacBio scientists to provide seamless integration and support for customers who are just starting out with PacBio or expanding their current capabilities.

PR Newswire
Feb 7th, 2024
Volta Labs And Element Biosciences Announce Collaboration To Enable Walk-Away Sample Prep And Sequencing On The Aviti™ System

BOSTON and SAN DIEGO, Feb. 7, 2024 /PRNewswire/ -- Volta Labs , a genomics applications company, and Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced a collaboration to optimize sequencing throughput with the launch of Volta's Callisto™ Sample Prep System for Element's AVITI.The combination of Volta Labs' Callisto and availability of VoltaPrep™ kits to prepare libraries for the AVITI System provides an efficient and low-cost end-to-end sequencing solution for customers, removing bottlenecks and accelerating the time to results."The work done by Element to broaden access to affordable, high-quality sequencing is unprecedented," said Udayan Umapathi, CEO at Volta Labs. "With this partnership, we will join forces with the Element team to offer an end-to-end solution to break the sample prep bottleneck and support sequencing at scale.""When we launched AVITI , it brought unmatched performance and affordability in benchtop sequencing. In commercial partnership with Volta Labs, we are taking another critical step to improve ease and accessibility to customers," said Yaron Hakak, PhD, SVP of Corporate and Business Development at Element Biosciences. "Labs will now have exceptional flexibility in the sequencing process from sample prep through analysis."This collaboration expands the reach of Volta's novel sample prep system, providing labs the flexibility to sequence smaller batches of reactions more frequently and at a lower cost. The Callisto Sample Prep System supports up to 24 reactions per run across at least eight applications, prepped for sequencing in hours

Yahoo Finance
Feb 6th, 2024
Volta Labs And Integrated Dna Technologies Partner To Advance Target Enrichment Workflows

BOSTON and CORALVILLE, Iowa, Feb. 6, 2024 /PRNewswire/ -- Volta Labs , a genomics applications company, and Integrated DNA Technologies (IDT) , a leading provider of differentiated next generation sequencing (NGS) solutions, announced a partnership to further the shared mission of making NGS solutions more accessible.Volta Labs, a genomics applications company, is transforming the way biological research and analyses are performed with a cutting-edge digital fluidics platform to maximize performance and scalability of sample preparation. (PRNewsfoto/Volta Labs Inc.)Volta Labs and IDT are working to create platform-agnostic solutions, with the goal of walk-away sample prep, starting with target enrichment workflows. With the recent availability of Volta's Callisto™ Sample Prep System, IDT is supporting the development of VoltaHyb™ applications. Initial study shows capture metrics and variant calling results were comparable or better for libraries processed using the Volta Labs benchtop instrument. Data will be presented at the 2024 AGBT General Meeting."While sequencing technologies have come a long way, the quality of sample prep still dictates the accuracy of the results," said Nick Downey, NGS Collaborations Lead at IDT

PR Newswire
Feb 5th, 2024
Volta Labs And Watchmaker Genomics Partner To Simplify And Optimize Ngs Library Prep

BOSTON and BOULDER, Colo., Feb. 5, 2024 /PRNewswire/ -- Volta Labs , a genomics applications company, and Watchmaker Genomics , a supplier of innovative products for molecular analysis, partner to leverage their technologies to power Volta's short-read library prep kits.Volta Labs and Watchmaker Genomics are jointly committed to making efficient, accessible, and cost-effective library prep a reality. With the launch of Volta's Callisto™ Sample Prep System, Watchmaker Genomics will provide the reagents behind various VoltaPrep™ library prep kits."Volta's digital fluidics technology and their approach to building automated sample prep applications are impressive," said Trey Foskett, CEO of Watchmaker Genomics. "Watchmaker has a passion for delivering superior data quality with simple and automatable workflows. Combining Volta's cutting-edge technology with our innovative reagents delivers in both of these areas, and we look forward to a continued partnership.""Watchmaker has set the bar high for enzyme engineering and library prep workflow development," said Udayan Umapathi, CEO at Volta Labs. "We are energized to work with their talented team to address quality, cost, and scalability challenges that currently exist in sample prep

BNN Bloomberg
Feb 5th, 2024
Volta Labs and Watchmaker Genomics Collaborate to Revolutionize Genomic Analysis

Volta Labs partners with Watchmaker Genomics to enhance their technologies and make genomic analysis more efficient, accessible, and cost-effective.

INACTIVE